12/16/2025
✨ PRIME Nexus® expands into large-volume delivery. ✨
Portal has now demonstrated 5.5 mL subcutaneous delivery on the PRIME Nexus platform, unlocking new possibilities for emerging biologics and long-acting formulations.
PRIME Nexus is purpose-built for large volumes and high-viscosity formulations, using software-controlled injection profiles to deliver consistent, comfortable injections, even for demanding use cases.
With its reusable device architecture, PRIME Nexus provides a sustainable and cost-efficient path across development, clinical use, and lifecycle management.
And because the platform was designed with scalability in mind, it creates a strong foundation for exploring even larger volumes in the future.
A flexible platform for today’s needs and tomorrow’s requirements.
Interested in learning more? Connect with us at partnering@portalinstruments.com